Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Expanding The Medtech Toolbox: US FDA's 'Medical Device Development Tools' Program Rolls Out

Executive Summary

Three years in the making, FDA has released a final guidance for medical device development tools that would allow developers to qualify their MDDTs and give medical device manufactures access to new tools that could help them prove safety and effectiveness of their products sooner.

Advertisement

Related Content

5 Ideas To Improve Device Cybersecurity
Shuren: More Than A Dozen MDDTs Under Review, But No More This Year
Established Heart Survey Clinches First MDDT Qualification
Leveraging mHealth Data For Product Development: FDA-Supported Action Plan Released
EnteroMedics Eyes First Commercial Maestro Implants For Obesity After Months Of Prep
FDA Launches Pilot Program To Qualify Medical Device Development Tools
FDA Expects Guidance On Validating Device Development Tools To Speed Approvals
FDA Validates Tool For Incorporating Patient Preferences In Regulatory Decisions

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT105331

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel